Among patients with hyperuricemia on hemodialysis, allopurinol significantly decreased cardiovascular risks, whereas febuxostat did not. Allopurinol and febuxostat both reduce death risk in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results